Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer
PaperCitations, authors & open-access status
Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 195 citations, 2010 year and bronze oa status.
195
Citations
2010
Year
bronze
OA Status